当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析 - 现金流量表

方盛制药

(603998)

  

流通市值:51.20亿  总市值:51.20亿
流通股本:4.39亿   总股本:4.39亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,235,533,947.85796,406,749.01378,348,512.331,763,106,017.41
  收到的税费返还824,405.67824,405.67584,472.476,787,408.97
  收到其他与经营活动有关的现金66,449,232.1939,986,016.2915,465,268.2853,087,188.93
  经营活动现金流入小计1,302,807,585.71837,217,170.97394,398,253.081,822,980,615.31
  购买商品、接受劳务支付的现金252,968,227.86164,043,152.5689,769,740.77442,060,512.05
  支付给职工以及为职工支付的现金206,545,038.99143,436,506.579,133,811.74277,721,938.18
  支付的各项税费143,270,208.395,002,019.4249,818,813.97206,621,249.64
  支付其他与经营活动有关的现金475,147,864.82305,247,124.82153,749,787.25701,629,476.88
  经营活动现金流出小计1,077,931,339.97707,728,803.3372,472,153.731,628,033,176.75
  经营活动产生的现金流量净额224,876,245.74129,488,367.6721,926,099.35194,947,438.56
二、投资活动产生的现金流量:
  收回投资收到的现金559,645,427.6247,001,788.8921,000,00098,515,561.9
  取得投资收益收到的现金443,534.59257,825.1882,964.38339,378.95
  处置固定资产、无形资产和其他长期资产收回的现金净额1,923,0201,309,140500,96028,954,373.24
  处置子公司及其他营业单位收到的现金净额24,398,706.2624,398,706.2624,563,206.2622,892,402.21
  收到的其他与投资活动有关的现金53,729,00047,729,00033,000,00062,800,000
  投资活动现金流入小计640,139,688.45320,696,460.3379,147,130.64213,501,716.3
  购建固定资产、无形资产和其他长期资产支付的现金63,509,679.0147,298,903.2817,502,125.9694,789,595.67
  投资支付的现金525,000,000260,000,00060,430,15077,668,532.03
  投资活动现金流出小计588,509,679.01307,298,903.2877,932,275.96172,458,127.7
  投资活动产生的现金流量净额51,630,009.4413,397,557.051,214,854.6841,043,588.6
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,080,0004,625,0002,325,0003,930,000
  其中:子公司吸收少数股东投资收到的现金9,080,0004,625,0002,325,0003,930,000
  取得借款收到的现金333,400,000329,400,000155,000,000906,664,583.33
  筹资活动现金流入小计342,480,000334,025,000157,325,000910,594,583.33
  偿还债务支付的现金508,750,000486,750,000272,300,000883,886,215
  分配股利、利润或偿付利息支付的现金197,375,585.2128,446,788.1730,543,760.21136,507,131.85
  其中:子公司支付给少数股东的股利、利润7,006,5007,006,500-7,006,500
  支付其他与筹资活动有关的现金39,483,005.4743,063,982.19830,263.4112,201,281.59
  筹资活动现金流出小计745,608,590.67658,260,770.36303,674,023.621,032,594,628.44
  筹资活动产生的现金流量净额-403,128,590.67-324,235,770.36-146,349,023.62-122,000,045.11
四、汇率变动对现金及现金等价物的影响-16,775.9-0.19-0.060.67
五、现金及现金等价物净增加额-126,639,111.39-181,349,845.83-123,208,069.65113,990,982.72
  加:期初现金及现金等价物余额296,028,848.51296,022,032.75296,022,033.54182,031,050.03
  期末现金及现金等价物余额169,389,737.12114,672,186.92172,813,963.89296,022,032.75
补充资料:
  净利润-166,494,080.22-249,848,866.44
  资产减值准备-54,625.6-20,619,446.54
  固定资产和投资性房地产折旧-29,316,359.35-55,587,619.26
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-29,316,359.35-55,587,619.26
  无形资产摊销-9,533,315.01-18,045,879.24
  长期待摊费用摊销-4,055,262-8,601,521.67
  处置固定资产、无形资产和其他长期资产的损失--20,669,772.23--746,351.63
  固定资产报废损失-27,753.74-46,383.33
  公允价值变动损失---21,182.07
  财务费用-6,335,566.43-13,618,975.51
  投资损失--1,376,986.92--38,557,369.89
  递延所得税--667,698.79-4,364,520.63
  其中:递延所得税资产减少-339,791.29-5,133,494.28
    递延所得税负债增加--1,007,490.08--768,973.65
  存货的减少--7,286,195.93--62,360,905.4
  经营性应收项目的减少--31,365,812.96--54,606,588.82
  经营性应付项目的增加--30,594,313.33--30,742,973.91
  其他-175,229.28-3,403,240.22
  现金的期末余额-114,672,186.92-296,022,032.75
  减:现金的期初余额-296,022,032.75-182,031,050.03
  现金及现金等价物的净增加额--181,349,845.83-113,990,982.72
公告日期2025-10-242025-08-292025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑